We report that sphingosine and short-chain ceramides activate adenylate cyclase and stimulate intracellular cyclic AMP formation in airway-smooth-muscle (ASM) cells. In each case, there is a conditional requirement for GTP-G s α. Sphingosine utilizes a protein kinase C-dependent pathway to elicit activation of adenylate cyclase, whereas for short-chain ceramides the mechanism remains unidentified. In contrast, sphingosine phosphate inhibits G s -stimulated cyclic AMP formation via a G i -dependent mechanism.Therefore, the potential interconversion of sphingosine and sphingosine phosphate is a switch that can elicit reciprocal changes in cyclic AMP levels. This may have a significant impact upon the regulation of extracellular signalregulated kinase (ERK) and c-Jun N-terminal specific kinase (JNK) by sphingolipids and may help to explain how growth factors that utilize these second messengers evoke pleiotropic responses such as proliferation and cell survival. In this context, short-chain ceramides are poor stimulators of ERKs in ASM
INTRODUCTION
Agonist-dependent activation of sphingomyelinase elicits the formation of ceramide from plasma-membrane sphingomyelin [1, 2] . For instance, ceramide is released as a consequence of tumour-necrosis-factor-α-stimulated sphingomyelin hydrolysis and can elicit both the autophosphorylation of a novel 97 kDa proline-directed protein kinase [3] and the activation of a specific PP2A-like phosphatase [4] . This novel kinase\phosphatase may perform an important role in NF-κB activation and internucleosomal fragmentation of DNA (for a review, see [5] ). Ceramide has also been demonstrated to inhibit lysophosphatidate-stimulated DNA synthesis in rat-1 fibroblasts [6] and can provoke the activation of mitogen-activated protein kinase (MAPK) [extracellular signal-regulated kinases (ERK) -1 and -2] in HL60 cells [7] .
In Swiss 3T3 fibroblasts, ceramide is converted sequentially into sphingosine and sphingosine phosphate, the latter step being catalysed by a specific sphingosine kinase [8] . Sphingosine and sphingosine phosphate stimulate phospholipase D (PLD) activity and can promote cell proliferation [8] [9] [10] . Sphingosine also elicits the in itro inhibition of phosphatidate phosphohydrolase and protein kinase C and the activation of diacylglycerol kinase Abbreviations used : ASM, airway smooth muscle ; C16-ceramide, N-palmitoylsphingosine ; C2-ceramide, N-acetylsphingosine ; C6-ceramide, Nhexanoylsphingosine ; DHS, donor horse serum ; DME, Dulbecco's modified Eagles medium ; ERK-2, extracellular signal-regulated kinase-2 ; FCS, fetalcalf serum ; HRP, horseradish peroxidase ; JNK, c-Jun N-terminal-specific kinase ; MAPK, mitogen-activated protein kinase ; PDGF, platelet-derived growth factor ; PMA, phorbol 12-myristate 13-acetate ; PtdBut, phoshatidylbutanol ; NP40, Nonidet P40 ; MEK, mitogen-activated ERK kinase ; IBMX, 3-isobutyl-1-methylxanthine.
cells, and sphingosine is inactive, whereas both sphingolipids are powerful activators of the JNK module. Activated JNK catalyses N-terminal phosphorylation of c-Jun, a kinase cascade that programmes growth arrest. Therefore, in blocking ceramidestimulated ERK-2 activity, cyclic AMP may allow the ceramidedependent activation of JNK to programme cells to opt out of the cell cycle. In contrast, sphingosine phosphate activates ERK-2, potentiates growth-factor-stimulated DNA synthesis and fails to activate JNK, indicating that its sequential formation from ceramide and sphingosine may commit cells to DNA synthesis. ERK-2 can be activated by both cyclic AMP-sensitive c-Raf-1 kinase-dependent and cyclic AMP-insensitive c-Raf-1 kinaseindependent pathways in ASM cells. In this context, sphingosine phosphate activates ERK-2 exclusively via c-Raf-1 kinase. Sphingosine phosphate-stimulated ERK-2 activity is also abolished by pertussis toxin, indicating that c-Raf-1 kinase is activated via a G i -dependent mechanism.
[11 -13] . However, the relationship between these novel lipids, phosphatidate and mitogenic signal cascades, such as ERK, are not fully defined.
Of the signal components involved in the ERK signal cascade, c-Raf-1 kinase is believed to determine the flux through the pathway, this being governed by its ability to integrate multiple stimulatory intracellular signals, such as those arising from protein kinase C, G-protein βγ subunits and p21 ras [14] [15] [16] [17] . cRaf-kinase has also been demonstrated to be an important target for signals that block activation of ERK. These include cyclic AMP which, in fibroblasts, acts via protein kinase A to catalyse phosphorylation of an N-terminal Ser-43 in c-Raf-1 kinase. This phosphorylation is purported to block the association of c-Raf-1 kinase with p21 ras [18] [19] [20] . Recent studies have demonstrated that sphingosine phosphate inhibits both forskolin-and isoproterenol-stimulated cyclic AMP formation in Swiss 3T3 fibroblasts [21] , a response that is mediated by a pertussis-toxinsensitive G-protein and that may involve a novel G-proteinlinked receptor. However, there is no evidence that the products of sphingomyelin hydrolysis can stimulate cyclic AMP formation. This may, in part, be due to the complexity of ' rules ' that determine whether adenylyl cyclase can integrate multiple signals. For instance, G i -linked receptor agonists inhibit adenylate cyclase by utilizing G i α, although in the presence of coincidentally stimulated G s α, the corresponding G i βγ subunits can evoke marked stimulation of certain adenylate cyclase isoforms [22] . Furthermore, in airway-smooth-muscle (ASM) cells, phorbol 12-myristate 13-acetate (PMA) stimulates type 2 adenylate cyclase, although no measurable intracellular cyclic AMP response is apparent unless G s α is coincidentally activated [23] .
We have, therefore, assessed whether sphingomyelin-derived lipids can interact with the ERK-module in ASM cells. We conclude that only sphingosine phosphate elicits a substantial activation of c-Raf-1 kinase-dependent ERK-2, inhibits G sstimulated cyclic AMP formation and potentiates plateletderived-growth-factor (PDGF)-stimulated DNA synthesis. When G s α is activated, sphingosine and short-chain ceramides elicit cyclic AMP formation and this may represent a generalized signalling pathway that inhibits sphingolipid-dependent activation of the ERK module. This may be important in allowing concurrent flux through c-Jun N-terminal-specific kinase (JNK) to programme cells to opt out of the cell cycle, whereas the sequential formation of sphingosine phosphate from ceramide and sphingosine may commit cells to DNA synthesis.
MATERIALS AND METHODS

Materials
General chemicals, myelin basic protein, collagenase, elastase and soya-bean trypsin inhibitor were from Sigma Chemical Co. 
Cell culture
The preparation of primary cultures of guinea-pig ASM cells was achieved as described previously [24] . The cells were maintained in Dulbecco's modified Eagle's medium (DME) containing 10 % (v\v) foetal-calf serum (FCS) and 10 % (v\v) donor horse serum (DHS) and were passaged twice, using trypsin, prior to experimentation. Cells were grown to confluence on 24-or sixwell plates and routinely used between passage number 3 and 4 after the initial preparation. Their identity was confirmed to be smooth muscle by the presence of α-actin using a smoothmuscle-specific mouse anti α-actin monoclonal antibody [24] .
PLD assays
Confluent ASM cells were preincubated with [$H]palmitate (2 µCi\ml) in DME containing 1 % (v\v) FCS and 1 % (v\v) DHS for 24 h. This procedure has previously been shown to result in the preferential incorporation of radioactivity into phosphatidylcholine, which contains 82 % of the total lipidassociated radioactivity in comparison with only 6 % associated with phosphatidylinositol, phosphatidylethanolamine, and phosphatidylserine combined [24] . PLD activity was determined using a transphosphatidylation assay as described by us previously [24] . Briefly, cells were washed and preincubated in KrebsHenseleit buffer before preincubation in the presence of 0.3 % (v\v) butan-1-ol for 5 min prior to separate challenge with PMA, C2-, C6-ceramides, sphingosine and sphingosine phosphate for 10 min at 37 mC. A lipid extract of the cells was prepared and [$H]phosphatidylbutanol ([$H]PtdBut), which is a direct indicator of PLD activity [24] , isolated by TLC using the upper phase of ethyl acetate\2,2,4-trimethylpentane (iso-octane)\water\acetic acid (11 : 5 : 10 : 2, by vol.). The R F value of PtdBut, determined using an internal standard, was approx. 0.35.
Cyclic AMP measurements
ASM cells were placed in DME containing 1 % (v\v) FCS and 1 % (v\v) DHS for 24 h before use. Where indicated, cells were preincubated for 18 h with cholera toxin (0.5 ng\ml). Under these conditions only a small proportion of the total G s α is activated [23] . The cells were washed twice in gassed (O # \CO # , 19 : 1) Krebs-Henseleit buffer, pH 7.4, and preincubated in KrebsHenseleit buffer with 1 % (w\v) BSA for 30 min at 37 mC in air :CO # (19 : 1). The cells were then challenged with final concentrations of either bradykinin (100 nM), PMA (100 nM), C2 dihydro-, C2-and C6-ceramides, sphingosine and sphingosine phosphate (all at a concentration of 0.125-125 µM) or sphingomyelinase (0.1-10 units\ml) for indicated times at 37 mC. In some cases, cells were pretreated for 5 min with Ro318220 (10 µM), a selective protein kinase C inhibitor. We have previously demonstrated that Ro318220 blocks protein kinase C-stimulated cyclic AMP formation [25] .
Incubations were terminated by the precipitation of the cells in 80 % (v\v) ethanol. Samples were harvested and centrifuged at 14 000 g and the cyclic AMP was extracted into ethanol, and then freeze-dried. Samples were taken for cyclic AMP determination using the [$H]cyclic AMP binding assay with bovine heart cyclic AMP-binding protein that had been purified by us by the method of Rubin et al. [26] . 
Detection of ERK-2 : shift assay
Cells were placed in DME containing 1 % (v\v) FCS and 1 % (v\v) DHS for 24 h. Cells were separately stimulated with PDGF (10 ng\ml), C2-, C16-and C6-ceramides, sphingosine and sphingosine phosphate (all at a final concentration of 100 µM). In some cases cells were preincubated for 18 h with either pertussis toxin (0.1 µg\ml) or cholera toxin (0.5 ng\ml). After treatment, for indicated times, the medium was removed and boiling sample buffer [0.125 M Tris\HCl (pH 6.7)\0.5 mM Na % P # O ( \1.25 mM EDTA\2.5 % (v\v) glycerol\0.5 % (w\v) SDS\25mM dithiothreitol) was added and the cell lysates harvested. Samples were boiled for 5 min and then subjected to SDS\PAGE and trans-ferred to nitrocellulose sheets. These were subsequently blocked in 5 % gelatin in PBS, pH 6.8, at 37 mC for 1 h and then probed with an anti-ERK-1\2 antibody. Antibody was diluted 1 : 2000 (v\v) in 1 % gelatin (w\v) and PBS plus 0.05 % (v\v) Nonidet P40 (NP40). Nitrocellulose sheets were incubated with primary antibody at 37 mC for 12 h at 37 mC, prior to washing sequentially three times in PBS plus 0.05 % (v\v) NP40. Detection of ERK-1\2 reactivity was achieved with a reporter HRP-linked antimouse antibody (1 : 2000 dilution, v\v) in 1 % gelatin (w\v) and PBS plus 0.05 % (v\v) NP40. Incubations were performed at 37 mC for 2 h. After washing the blots as described above, to remove excess reporter antibody, immunoreactive bands were detected with the ECL detection kit.
c-Raf-1 kinase immunoprecipitation
Cells were placed in DME containing 1 % (v\v) FCS and 1 % (v\v) DHS for 24 h. After stimulation with sphingosine phosphate (100 µM), the medium was removed. Cells were lysed in ice-cold 1 % Triton X-100\150 mM NaCl\10 mM Tris\HCl (pH 7.4)\1 mM EDTA\1 mM EGTA\0.5 mM Na $ VO % \20 mMNaF\0.2 mM PMSF\0.5 % NP40 for 30 min. The material was harvested, centrifuged at 14 000 g for 10 min at 4 mC and 200 µl of cell lysate supernatant (equalized for protein) was taken and immunoprecipitated with specific antibodies o1 µg of antibody, 500 µl of water and 300 µl of i2 immunoprecipitation buffer [1 % Triton X-100\150 mM NaCl\10 mM Tris\HCl (pH 7.4)\1 mM-EDTA\1 mM EGTA\0.2 mM Na $ V0 % \20 mM NaF\ 0.2mM PMSF\0. 
RESULTS
Sphingolipids and cyclic AMP signalling
Recent studies in Swiss 3T3 fibroblasts have demonstrated that sphingosine phosphate inhibits both forskolin-and isoproterenol-stimulated cyclic AMP formation via a pertussistoxin-sensitive G-protein [21] . In order to establish the wider significance of these findings, we have assessed the role of sphingosine phosphate in ASM cells. We have also separately measured the effect of short-chain ceramides and sphingosine, in order to establish whether the potential interconversion of these sphingolipids in i o is likely to influence cyclic AMP signalling in mammalian cells. Consistent with studies by Spiegel and colleagues [21] , sphingosine phosphate elicits a partial inhibition of cholera-toxin-stimulated cyclic AMP formation in ASM cells (Figure 1 ), whilst pertussis toxin (0.1 µg\ml) blocks this reduction (results not shown). This indicates that sphingosine phosphate utilizes G i , since ASM cells do not express the alternative pertussis-toxin substrate, G o [27] . However, in cells treated with cholera toxin (0.5 ng\ml), short-chain (C2-and C6-) ceramides and sphingosine stimulate a concentration-dependent increase in cyclic AMP (Figures 2a-2c ). This may play an important role in the regulation of cell proliferation, since cyclic AMP inhibits DNA synthesis and a maintained stimulation of cyclic AMP formation is expected to elicit growth arrest. However, a reduction in intracellular cyclic AMP in response to sphingosine phosphate is consistent with the ability of this sphingolipid to potentiate PDGF-stimulated DNA synthesis ( Figure 3 ). These studies are important when considering the action of growth factors, such as PDGF, which stimulates sphingomyelin turnover and the acute activation of sphingosine kinase [8] , resulting in reciprocal changes in ceramide and sphingosine phosphate levels in intact cells [8] .
These data suggest that the addition of sphingomyelinase to intact cholera-toxin-treated cells should generate sufficient quantities of ceramide and sphingosine to affect cyclic AMP formation, and this is indeed the case (Figure 2d) . Importantly, the biologically inactive C2-dihydroceramide is completely ineffective at stimulating cyclic AMP formation [cholera-toxin-treated, basal, 1.75p0.29 ; C2-dihydroceramide (125 µM), 1.9p0.5 (pmol\0.25i10' cells ; n l 3 separate experiments)], indicating that the unsaturated C-C bond in the 4-5 position of ceramide is critical. Therefore, the specificity for unsaturated ceramide indicates that cyclic AMP formation is independent of nonspecific lipid interactions.
Mechanisms regulating cyclic AMP signalling
If short-chain ceramides and sphingosine elicit an increase in cyclic AMP via the activation of adenylate cyclase, then the phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (IBMX) (100 µM) will theoretically potentiate each cyclic AMP response. In Table 1 we demonstrate that this is the case. Equally, if short-chain ceramides and sphingosine inhibit cyclic AMP phosphodiesterase, they should mimic the phosphodiesterase inhibitor IBMX and potentiate forskolinstimulated cyclic AMP formation. Indeed, this potentiation should exceed that induced by IBMX. This is based upon the observation that IBMX elicits an increase in intracellular cyclic AMP in cholera-toxin-treated cells that is smaller in magnitude to that elicited by either sphingosine or C6-ceramide (Table 1) . However, whilst IBMX markedly potentiates forskolinstimulated cyclic AMP formation, both C6-ceramide and sphingosine were ineffective ( Table 1 ), indicating that they do not exhibit the characteristics of a phosphodiesterase inhibitor. Indeed, IBMX can still potentiate forskolin-stimulated cyclic AMP formation even in cells concurrently stimulated with C6-ceramide ( Table 1) . We therefore conclude that sphingosine and ceramide represent novel regulators of adenylyl cyclase. This is supported by the observation demonstrating that the inhibition of adenylate cyclase by SQ22536 (100 µM) blocks both sphingosine-and C6-ceramide-stimulated cyclic AMP formation ( Table 2 ). In each case the stimulation of cyclic AMP formation displays a conditional requirement for the coincident activation of G s α.
Ro318220, a potent protein kinase C inhibitor, attenuates sphingosine-stimulated cyclic AMP formation but fails to modulate the action of C6-ceramide (Table 3 ). We also demonstrate that Ro318220 inhibits PMA-and bradykinin-stimulated cyclic AMP formation (Table 3) . We have previously proposed that bradykinin regulates the type 2 adenylate cyclase via a protein kinase C-dependent pathway that is downstream of the PLDcatalysed hydrolysis of phosphatidylcholine [23] . In this regard, it is significant that only sphingosine stimulates PLD activity in
Table 2 Effect of the adenylyl cyclase inhibitor, SQ22536 on sphingolipidstimulated cyclic AMP formation in cholera toxin-treated ASM cells
Cholera-toxin-treated (0.5 ng/ml) ASM cells were incubated in the absence or presence of SQ22536 (100 µM) for 15 min prior to challenge for 10 min with either C6-ceramide (125 µM) or sphingosine (125 µM). Cyclic AMP values (meanpS.D., n l 3 separate cell preparations) are expressed as pmol/0.25i10 6 cells. *P 0.01 versus cyclic AMP response in the absence of SQ22536 (100 µM). DMSO (1 % final concn.) was included in the control and all the treatments. 
Table 3 Effect of Ro318220 upon bradykinin-, PMA-, sphingosine-and C6-ceramide-stimulated cyclic AMP formation in cholera-toxin-treated ASM cells
The effect of bradykinin-(100 nM), PMA-(100 nM), C6-ceramide-(125 µM) and sphingosine-(125 µM) on cyclic AMP formation in cholera-toxin-treated (0.5 ng/ml) ASM cells in the presence and absence of Ro318220 (10 µM (Table 4 ) and is therefore the only sphingolipid that can potentially activate protein kinase C via this route. In this context, it is also important to note that the type 2 adenylate cyclase is characterized by its ability to detect and integrate coincident G s α and protein kinase C signals [25] . The formation of cyclic AMP in response to short-chain ceramides and sphingosine are kinetically distinct. C6-and C2-ceramide stimulate cyclic AMP formation with sustained kinetics (Figure 4) , whereas sphingosine elicits transient cyclic AMP formation, characterized by a rapid increase in the cyclic AMP signal which slowly declines to below basal levels after 45 min of cell stimulation (Figure 4) . We cannot exclude the possibility that sphingosine is slowly converted into sphingosine phosphate under these conditions. As shown in Figure 1 , sphingosine phosphate inhibits G s -stimulated cyclic AMP formation and may account for the transient cyclic AMP response. In contrast, the direct addition of sphingosine phosphate to cells elicits an acute inhibition of cholera-toxin-stimulated cyclic AMP formation, followed by a delayed increase in cyclic AMP levels (t 10 min), probably a consequence of its slow back-conversion into sphingosine (results not shown).
Table 4 Effect of PMA, sphingosine, sphingosine phosphate and C6-ceramide on PLD activity in ASM cells
The effect of dihydro-C2-ceramide (100 µM), C6-ceramide (100 µM), PMA (100 nM), sphingosine (100 µM) and sphingosine phosphate (100 µM) on 
Effect of sphingolipids on ERK-2 activity : modulation by cholera and pertussis toxin
ERK-2 is expressed as a 42 kDa MAPK and its activation in response to both growth-factor and G-protein-linked-receptor stimulation is indicated by its retarded electrophoretic mobility upon SDS\PAGE : a consequence of its phosphorylation by its ' upstream ' activating kinase, MEK. A maximal concentration of PDGF (10 ng\ml) can induce rapid activation of ERK-2, resulting in all of the immunodetected ERK-2 displaying retarded mobility on SDS\PAGE ( Figure 5 ). In contrast, cell-permeable ceramides (C2-and C16-ceramide) elicit an activation of ERK-2 which results in only a fraction of the immunodetected ERK-2 displaying retarded mobility ( Figure 5 ). Sphingosine is completely ineffective (Figure 5 ), although it does activate PLD activity in these cells (Table 4) . Sphingosine phosphate induces activation of at least 50 % of the immunodetected ERK-2 ( Figure 5 ), and we demonstrate here that it also activates c-Raf-1 kinase ( Figure 6 ). We have previously shown that ERK-2 can be activated by both c-Raf-1 kinase-
Figure 5 Effect of sphingolipids and cholera toxin on ERK-2
The Figure shows a shift blot demonstrating the sphingolipid-induced activation of ERK-2 and the inhibitory effect of cholera-toxin pre-treatment (0.5 ng/ml). Lanes 1 and 4, non-challenged cells ; lanes 2 and 5, C2-ceramide challenged (100 µM) ; lanes 3 and 6, C16-ceramidechallenged (100 µM). Lanes 1-3, control cells ; lane 4-6, cholera-toxin-treated cells. Lanes 7 and 10, PDGF-challenged (10 ng/ml) ; lanes 8 and 11, sphingosine-challenged (100 µM) ; lanes 9 and 12, sphingosine phosphate-challenged (100 µM). Lanes 7-9, control cells ; lanes 10-12, cholera-toxin-treated cells. This is a representative result of an experiment performed three times. ERK-1/2 and activated ERK-2 are denoted by arrows. dependent and independent pathways in ASM cells (N. J. Pyne and S. Pyne, unpublished work). Only the c-Raf-1 kinasedependent ERK-2 is inhibited by cyclic AMP. For this reason it is important to establish whether sphingosine phosphate can also activate ERK-2 via c-Raf-1 kinase-independent mechanism. In cholera-toxin-treated cells, the sphingosine phosphate-induced activation of ERK-2 is completely abolished (Figure 5 ), and this occurs despite the partial inhibition of cholera-toxin-stimulated cyclic AMP formation. Therefore, sphingosine phosphate activates ERK-2 via a c-Raf-1 kinase-dependent mechanism in these cells.
Pertussis toxin catalyses the ADP-ribosylation of the α subunits of G i and G o and in ASM cells inhibits sphingosine phosphatestimulated ERK-2 activity (Figure 7 ). ASM cells do not express G o [27] , indicating that G i probably couples to the ERK-2 module.
C2-ceramide-stimulated ERK-2 activity is also abolished by cholera toxin, an event that occurs concurrently with the amplification of cyclic AMP formation (Figures 2 and 5) .
DISCUSSION
Sphingosine and short-chain ceramides stimulate cyclic AMP formation in ASM cells. Cyclic AMP formation displays a conditional requirement for GTP-G s α and is mediated by a protein kinase C-and a novel-ceramide-dependent activation of adenylate cyclase. Therefore, the potential growth-factor-induced interconversion of sphingosine and sphingosine phosphate can result in reciprocal changes in cyclic AMP. In this regard, there is direct evidence that PDGF activates sphingosine kinase and the formation of sphingosine phosphate in Swiss 3T3 fibroblasts [8] . This may have a significant impact upon DNA synthesis, since cyclic AMP is inhibitory. Therefore, a reduction in the level of cyclic AMP may potentiate growth-factor-stimulated DNA synthesis. In support of this, sphingosine phosphate enhances PDGF-stimulated DNA synthesis in ASM cells. In contrast, short-chain ceramides and sphingosine are powerful activators of the JNK module (results not shown). Activated JNK catalyses N-terminal phosphorylation of c-Jun and evokes growth arrest [28] . When G s α is activated, sphingosine and short-chain ceramides elicit cyclic AMP formation, and this may represent a generalized signalling pathway that inhibits sphingolipid-dependent activation of the ERK module. This may be important in allowing concurrent flux through JNK to programme cells to opt out of the cell cycle. We do not know whether the relatively poor stimulation of ERKs in other cell systems is due to ceramidedependent stimulation of cyclic AMP formation. However, if a relatively small pool of activated G s is present in these cells, then conditional stimulation of cyclic AMP formation is possible.
Only one recently published article has demonstrated the stimulation of ERK-2 by sphingosine phosphate [29] . Whilst that study identified a role for a pertussis-toxin-sensitive G-protein, the authors were unable to discriminate whether either G i or G o is responsible for coupling to the ERK-2 module. Our study provides two novel aspects which are important advances. Firstly, in demonstrating that pertussis toxin blocks the activation of the ERK-2, we can establish that sphingosine phosphate utilizes G i . Secondly, we demonstrate for the first time that sphingosine phosphate-stimulated ERK-2 activity is completely inhibited by a cyclic AMP-dependent mechanism and therefore only utilizes c-Raf-1 kinase. We have previously shown that growth factors activate ERK-2 via both c-Raf-1 kinase-dependent and -independent pathways in ASM cells (results not shown). Only the c-Raf-1 kinase-dependent ERK-2 module is inhibited by cyclic AMP.
The ability of sphingosine phosphate to stimulate ERK-2 activity via a G i -dependent mechanism implicates a role for G i βγ subunits. The overexpression of βγ subunits in Cos-7 cells constitutively activates ERK [15, 16] , whereas expression of a mutant constitutively active form of G i α has no stimulatory effect. The βγ subunit dimer can bind to target proteins via a pleckstrin homology domain [15] , and a number of p21 rasassociated proteins contain this domain. The association of βγ subunit with these proteins may stimulate GTP loading of p21 ras , thereby enabling c-Raf-1 kinase docking and localization in the plasma membrane. Furthermore, G-protein βγ subunits can activate an unidentified kinase that catalyses the rapid tyrosyl phosphorylation of Shc and the consequential recruitment of a Grb-mSos complex and the GTP loading of p21 ras [30] .
Sphingomyelin-derived lipids can also elicit rapid regulation of the hydrolysis of choline-containing phospholipids. Phosphatidate has also been demonstrated to prolong the lifetime of GTP-loaded p21 ras [31] via activation of a GTPase inhibiting protein and inhibition of a GTPase-activating protein (GIP\GAP ; [31] ). The prolonged activation of p21 ras is expected to sustain the stimulation of ERK-2 via a p21 ras \c-Raf-1 kinase pathway. However, phospholipase D-derived phosphatidate is not sufficient alone to stimulate ERK-2, since sphingosine can modulate PLD activity in the absence of ERK-2 activation.
We conclude that the interconversion of sphingolipids enables diverse signal pathways to be activated, all of which can contribute to pleiotropic cell responses.
